Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Pharmacoeconomics|November 8, 2017
Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix®) to Guide Treatment of Patients with Depression and/or AnxietyMehdi Najafzadeh, Jorge A Garces, Alejandra MacielPharmacogenetics and Genomics|November 10, 2015
CYP2D6 copy number distribution in the US populationMichelle Beoris, Jean Amos Wilson, Jorge A Garces, et al.Journal of Managed Care & Specialty Pharmacy|July 31, 2018
Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive DisorderErik J Groessl, Steven R Tally, Naomi Hillery, et al.Pharmacogenomics and Personalized Medicine|February 9, 2016
Initial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facilityJuan-Sebastian Saldivar, David Taylor, Elaine A Sugarman, et al.The Primary Care Companion for CNS Disorders|March 18, 2017
Clinical Impact of Pharmacogenetic-Guided Treatment for Patients Exhibiting Neuropsychiatric Disorders: A Randomized Controlled TrialMarilyn C Olson, Alejandra Maciel, Jean Francois Gariepy, et al.Journal of Psychiatric Research|October 10, 2017
Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utilityPaul Bradley, Michael Shiekh, Vishaal Mehra, et al.Pageof 1